Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126192191 | 12619219 | 1 | I | 20160725 | 20160803 | 20160803 | PER | US-EMD SERONO-8098983 | EMD SERONO INC | 0.00 | M | Y | 0.00000 | 20160803 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126192191 | 12619219 | 1 | PS | REBIF | INTERFERON BETA-1A | 1 | U | 103780 | INJECTION | ||||||||||
| 126192191 | 12619219 | 2 | C | AMPYRA | DALFAMPRIDINE | 1 | Oral | 3 TO 4 YEARS AGO | 076251 | 0 | 10 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126192191 | 12619219 | 1 | Multiple sclerosis |
| 126192191 | 12619219 | 2 | Multiple sclerosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126192191 | 12619219 | Injection site erythema | |
| 126192191 | 12619219 | Injection site pain | |
| 126192191 | 12619219 | Mobility decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |